Clinical Trial Update: Safety of HRX215 in Patients After Minor and Major Liver Resection [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the safety of HRX215 in patients after minor and major liver resection. The study is in Phase 1 and Phase 2 and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• HRX215

Snippet

Sponsor: HepaRegeniX GmbH | Conditions: Liver Resection, Colorectal Carcinoma Liver Metastases | Phase 1, Phase 2 | Status: RECRUITING